
# Title 42 - Public Health
## Chapter I - Public Health Service, Department of Health and Human Services
### Subchapter A - General Provisions
#### PART 11 - CLINICAL TRIALS REGISTRATION AND RESULTS INFORMATION SUBMISSION
##### Subpart C - Results Information Submission
###### ยง 11.48 What constitutes clinical trial results information?
####### Additional clinical trial results information for applicable device clinical trials of unapproved or uncleared device products.

(7)(i) For an applicable device clinical trial of an unapproved or uncleared device product and for which clinical trial registration information has not been posted publicly on Clinical Trials.gov by the Director in accordance with ยง 11.35(b)(2)(i), the responsible party must provide the following data elements, as the data elements are defined in ยง 11.10(b): Brief Title; Official Title; Brief Summary; Primary Purpose; Study Design; Study Type; Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study; Intervention Name(s); Other Intervention Name(s); Intervention Description; Intervention Type; Device Product Not Approved or Cleared by U.S. FDA, if any studied intervention is a device product; Study Start Date; Primary Completion Date; Study Completion Date, Enrollment; Primary Outcome Measure Information; Secondary Outcome Measure Information; Eligibility Criteria; Sex/Gender; Age Limits; Accepts Healthy Volunteers; Overall Recruitment Status; Why Study Stopped; Name of the Sponsor; Responsible Party, by Official Title; Facility Name and Facility Location, for each participating facility in a clinical trial; Unique Protocol Identification Number; Secondary ID; Human Subjects Protection Review Board Status; and Record Verification Date.
